Scholars Central

Review articlePublished 27 Apr 2023

Pharmacokinetic and Pharmacodynamics Effects of Infliximab in Children with Ulcerative Colitis

Authors: Sara Joseph

Department of Paediatric Medicine, Faculty of Family Medicine, Helwan University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The colon is largely impacted by the chronic gastrointestinal inflammatory illness known as ulcerative colitis (UC). Patients with UC experience chronic inflammation of the colon's surface mucosa, crypt epithelium, and/or submucosa, which results in bloody diarrhoea, stomach pain, weight loss, and fever. Although UC symptoms are similar in both adults and children, pediatric-onset UC is more usually associated with acute severe exacerbations because it tends to be more severe than in adult patients. This study's primary goal is to evaluate infliximab pharmacokinetics in children with ulcerative colitis (UC).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmacokinetics & Experimental Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacokinetics & Experimental Therapeutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sara Joseph”